HSG Holding’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.5M Hold
3,750,299
– – 2.17% 8
2026
Q2
$24.7M Buy
+3,750,299
New +$25.5M 1.99% 7

Other funds holding GYRE

HSG Holding's GYRE Position: Q3 2026 in Review

HSG Holding held its Gyre Therapeutics (GYRE) position steady in Q3 2026 at 3,750,299 shares worth $27.5M. The position accounts for 2.17% of the portfolio, ranked #8.

HSG Holding first reported a position in GYRE in Q2 2026 and has held it in 2 quarters since. 58 funds tracked by Wall St. Rank hold GYRE as of Q3 2026.

  • HSG Holding held 3,750,299 shares of Gyre Therapeutics worth $27.5M as of Q3 2026.
  • HSG Holding left its Gyre Therapeutics share count unchanged in Q3 2026.
  • Gyre Therapeutics made up 2.17% of HSG Holding's portfolio in Q3 2026, its #8 holding.
  • HSG Holding first reported a position in Gyre Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 58 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2026.

Based on HSG Holding's 13F filing for Q3 2026, filed 13 Nov 2026.